Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors
- 1 June 2004
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 59 (2) , 501-508
- https://doi.org/10.1016/j.ijrobp.2003.11.001
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Primary central nervous system lymphomasCancer, 2002
- Importance of Radiotherapy in the Outcome of Patients With Primary CNS Lymphoma: An Analysis of the CHOD/BVAM Regimen Followed by Two Different Radiotherapy TreatmentsJournal of Clinical Oncology, 2002
- Primary central nervous system non-hodgkin’s lymphoma (PCNSL): survival advantages with combined initial therapy? a final report of the north central cancer treatment group (NCCTG) study 86-72-52International Journal of Radiation Oncology*Biology*Physics, 1999
- Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapyNeurology, 1996
- Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcomeJournal of Neurosurgery, 1994
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315International Journal of Radiation Oncology*Biology*Physics, 1992
- Primary non-Hodgkin's lymphoma of the central nervous system: Phase II study of chemotherapy (BVAM) prior to radiotherapyClinical Oncology, 1991
- Primary central nervous system lymphomaJournal of Neurosurgery, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958